Matches in Wikidata for { <http://www.wikidata.org/entity/Q57157801> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q57157801 description "article" @default.
- Q57157801 description "im September 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57157801 description "wetenschappelijk artikel" @default.
- Q57157801 description "наукова стаття, опублікована у вересні 2018" @default.
- Q57157801 name "Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China" @default.
- Q57157801 name "Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China" @default.
- Q57157801 type Item @default.
- Q57157801 label "Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China" @default.
- Q57157801 label "Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China" @default.
- Q57157801 prefLabel "Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China" @default.
- Q57157801 prefLabel "Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China" @default.
- Q57157801 P1433 Q57157801-10C15DB2-CFAA-4A18-90D5-575B777E48F6 @default.
- Q57157801 P1476 Q57157801-C2515E2F-1D13-4554-90B3-6CBDE45DD08B @default.
- Q57157801 P2093 Q57157801-04B983B4-328E-4E43-85BA-FBA0A7CC49E5 @default.
- Q57157801 P2093 Q57157801-2355554C-28C1-405D-A2EB-4FB41307ABE8 @default.
- Q57157801 P2093 Q57157801-5A7E3501-7642-456C-BA0C-EF966DFC8C23 @default.
- Q57157801 P2093 Q57157801-680DED68-AB6D-47B7-A027-D1C735FBB86B @default.
- Q57157801 P2093 Q57157801-83552EC5-86C1-4646-8AEC-F7B212EA0BC8 @default.
- Q57157801 P2093 Q57157801-8B01343C-F1D7-48C5-94E6-E53879BE1CBC @default.
- Q57157801 P2093 Q57157801-942DC099-E3CC-4947-A140-9676F08FF342 @default.
- Q57157801 P2093 Q57157801-B85B7789-F47B-4721-8F03-9AAB454C2192 @default.
- Q57157801 P2093 Q57157801-BBDED61B-CC89-4BF8-A9CA-6A83AD03E9A6 @default.
- Q57157801 P2093 Q57157801-BFF510FC-E18D-4451-963A-BDD8AF99BAB5 @default.
- Q57157801 P2093 Q57157801-FA94B334-0E9F-460E-BEE8-820D74048994 @default.
- Q57157801 P304 Q57157801-30B3E10B-4FA6-4BC9-A545-5772E65E11AD @default.
- Q57157801 P31 Q57157801-9308CF3E-37D8-47C7-AEDF-BF50FC58E7AF @default.
- Q57157801 P356 Q57157801-5FBEF4C7-16CF-488D-A0E1-873DC4BFA6C9 @default.
- Q57157801 P407 Q57157801-47F17E33-E088-4897-9772-17C1BF5E04A8 @default.
- Q57157801 P433 Q57157801-CDF81C69-D08F-4E0D-B787-61BF5417958E @default.
- Q57157801 P478 Q57157801-17DD20AE-3AED-43A4-871A-B5AFAF75B2E5 @default.
- Q57157801 P577 Q57157801-9624D132-884A-4262-8300-75ACE28FD8E1 @default.
- Q57157801 P698 Q57157801-F633B225-E225-4D16-8F33-64CAC0952301 @default.
- Q57157801 P921 Q57157801-695D7FA7-6E74-49C0-930C-31B8FF96D767 @default.
- Q57157801 P921 Q57157801-F8D075DA-C373-4FC8-A267-C8ABFEA5DE33 @default.
- Q57157801 P356 S00277-018-3488-1 @default.
- Q57157801 P698 30209556 @default.
- Q57157801 P1433 Q15766509 @default.
- Q57157801 P1476 "Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China" @default.
- Q57157801 P2093 "Bing Han" @default.
- Q57157801 P2093 "Daobin Zhou" @default.
- Q57157801 P2093 "Huacong Cai" @default.
- Q57157801 P2093 "Jian Li" @default.
- Q57157801 P2093 "Junling Zhuang" @default.
- Q57157801 P2093 "Miao Chen" @default.
- Q57157801 P2093 "Minghui Duan" @default.
- Q57157801 P2093 "Tienan Zhu" @default.
- Q57157801 P2093 "Wei Zhang" @default.
- Q57157801 P2093 "Xinxin Cao" @default.
- Q57157801 P2093 "Yan Zhang" @default.
- Q57157801 P304 "143-150" @default.
- Q57157801 P31 Q13442814 @default.
- Q57157801 P356 "10.1007/S00277-018-3488-1" @default.
- Q57157801 P407 Q1860 @default.
- Q57157801 P433 "1" @default.
- Q57157801 P478 "98" @default.
- Q57157801 P577 "2018-09-12T00:00:00Z" @default.
- Q57157801 P698 "30209556" @default.
- Q57157801 P921 Q422232 @default.
- Q57157801 P921 Q422252 @default.